Pamela Stuart Jones, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 9 | 2024 | 1326 | 1.460 |
Why?
|
Adenoma | 5 | 2022 | 2164 | 0.950 |
Why?
|
Pituitary ACTH Hypersecretion | 2 | 2024 | 180 | 0.860 |
Why?
|
Glioma | 5 | 2021 | 3532 | 0.720 |
Why?
|
Skull Base Neoplasms | 2 | 2014 | 281 | 0.710 |
Why?
|
Levulinic Acids | 1 | 2019 | 15 | 0.680 |
Why?
|
Protoporphyrins | 1 | 2019 | 170 | 0.650 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2024 | 958 | 0.550 |
Why?
|
Monitoring, Intraoperative | 2 | 2021 | 950 | 0.530 |
Why?
|
Craniopharyngioma | 4 | 2021 | 279 | 0.520 |
Why?
|
Photosensitizing Agents | 1 | 2019 | 631 | 0.490 |
Why?
|
Brain Neoplasms | 7 | 2024 | 9213 | 0.450 |
Why?
|
Chondrosarcoma | 1 | 2014 | 306 | 0.380 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 1933 | 0.380 |
Why?
|
Chordoma | 1 | 2014 | 349 | 0.360 |
Why?
|
Pathology, Molecular | 1 | 2013 | 329 | 0.340 |
Why?
|
Mutation | 9 | 2024 | 30266 | 0.260 |
Why?
|
Central Nervous System Neoplasms | 2 | 2024 | 930 | 0.230 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2059 | 0.230 |
Why?
|
Microelectrodes | 2 | 2021 | 308 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9442 | 0.210 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2021 | 247 | 0.200 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 194 | 0.190 |
Why?
|
Tumor Escape | 2 | 2021 | 372 | 0.190 |
Why?
|
Craniotomy | 3 | 2021 | 747 | 0.190 |
Why?
|
Meningeal Carcinomatosis | 1 | 2021 | 66 | 0.180 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 85 | 0.180 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2022 | 619 | 0.180 |
Why?
|
Pituitary Diseases | 1 | 2021 | 136 | 0.170 |
Why?
|
Telomerase | 2 | 2024 | 753 | 0.160 |
Why?
|
Aminolevulinic Acid | 1 | 2019 | 150 | 0.160 |
Why?
|
Tumor Burden | 2 | 2014 | 1913 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36861 | 0.150 |
Why?
|
Evoked Potentials, Motor | 1 | 2021 | 465 | 0.140 |
Why?
|
Acromegaly | 1 | 2020 | 316 | 0.140 |
Why?
|
Neoplasm, Residual | 2 | 2019 | 1019 | 0.130 |
Why?
|
Brain Mapping | 3 | 2021 | 6740 | 0.130 |
Why?
|
Glioblastoma | 2 | 2024 | 3525 | 0.130 |
Why?
|
Frontal Lobe | 1 | 2022 | 1428 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1900 | 0.120 |
Why?
|
Thalamus | 1 | 2021 | 1050 | 0.120 |
Why?
|
Accidental Falls | 1 | 2022 | 1080 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1376 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6546 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 1014 | 0.110 |
Why?
|
Adult | 18 | 2024 | 223818 | 0.100 |
Why?
|
Middle Aged | 17 | 2024 | 223740 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2022 | 65485 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 892 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2021 | 1258 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2020 | 1942 | 0.100 |
Why?
|
Aged | 13 | 2024 | 171790 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1176 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1437 | 0.100 |
Why?
|
Reoperation | 1 | 2022 | 4342 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1006 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2260 | 0.100 |
Why?
|
Humans | 31 | 2024 | 768887 | 0.090 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2830 | 0.090 |
Why?
|
Fourth Ventricle | 1 | 2011 | 32 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12093 | 0.090 |
Why?
|
Neurocysticercosis | 1 | 2011 | 91 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11886 | 0.080 |
Why?
|
Cell Survival | 1 | 2019 | 5794 | 0.080 |
Why?
|
Male | 18 | 2024 | 365249 | 0.080 |
Why?
|
Female | 19 | 2024 | 397464 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3608 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3326 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6318 | 0.080 |
Why?
|
Databases, Factual | 2 | 2014 | 8095 | 0.080 |
Why?
|
Ion Transport | 1 | 2009 | 322 | 0.080 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 17174 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1042 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8559 | 0.070 |
Why?
|
Inpatients | 1 | 2019 | 2570 | 0.070 |
Why?
|
Age Factors | 2 | 2014 | 18454 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9564 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9682 | 0.070 |
Why?
|
Young Adult | 6 | 2024 | 60110 | 0.070 |
Why?
|
Seizures | 1 | 2019 | 3000 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5707 | 0.060 |
Why?
|
Brain | 3 | 2022 | 27476 | 0.060 |
Why?
|
Electric Stimulation | 2 | 2021 | 1743 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2021 | 5834 | 0.060 |
Why?
|
Brain Edema | 1 | 2009 | 607 | 0.060 |
Why?
|
Hydrocephalus | 1 | 2011 | 770 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59738 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18366 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2024 | 81892 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10276 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4413 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5956 | 0.050 |
Why?
|
Prognosis | 3 | 2024 | 30044 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 4651 | 0.050 |
Why?
|
Infant | 2 | 2014 | 36541 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9524 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 56 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2024 | 5801 | 0.050 |
Why?
|
Child, Preschool | 2 | 2014 | 42684 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 152 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 363 | 0.040 |
Why?
|
Sex Factors | 1 | 2014 | 10641 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 228 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5323 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 310 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 566 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1748 | 0.040 |
Why?
|
United States | 3 | 2023 | 73180 | 0.040 |
Why?
|
Mice | 3 | 2021 | 82074 | 0.040 |
Why?
|
Nausea | 1 | 2021 | 682 | 0.040 |
Why?
|
Optical Phenomena | 1 | 2019 | 105 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 89247 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2021 | 634 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 593 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 516 | 0.040 |
Why?
|
Exanthema | 1 | 2021 | 503 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1256 | 0.030 |
Why?
|
4-1BB Ligand | 1 | 2016 | 29 | 0.030 |
Why?
|
OX40 Ligand | 1 | 2016 | 57 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3008 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1842 | 0.030 |
Why?
|
Child | 2 | 2014 | 80969 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1830 | 0.030 |
Why?
|
Animals | 4 | 2021 | 169408 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14751 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2365 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1557 | 0.030 |
Why?
|
K562 Cells | 1 | 2016 | 648 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1620 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2024 | 2110 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 386 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1244 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 2001 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1813 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2433 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2018 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4123 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2211 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2820 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39394 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6085 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2422 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2126 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12873 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 819 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6805 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22390 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54950 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1193 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1169 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41800 | 0.020 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2009 | 106 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2542 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10115 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2909 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 573 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4862 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1989 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4265 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 768 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 13020 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6525 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5505 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9549 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22294 | 0.010 |
Why?
|
Vaccination | 1 | 2016 | 3436 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 1036 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22381 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9499 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26384 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8240 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13054 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14199 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40266 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74971 | 0.010 |
Why?
|